Celastrol Suppresses Tryptophan Catabolism in Human Colon Cancer Cells as Revealed by Metabolic Profiling and Targeted Metabolite Analysis

Abstract

Celastrol is well known for its anti-cancer effects, yet its specific mechanisms against colon cancer are still not fully elucidated. In this study, cytotoxic effect of celastrol against HCT116 colon cancer cells was investigated based on cell viability assay and flow cytometry assay, and the possible mechanism was explored using a strategy combining metabolic profiling and targeted metabolite analysis based on ultra performance liquid chromatography (UPLC)/MS. Celastrol was found to inhibit the growth of colon cancer cells and induce apoptosis. Metabolomics analysis revealed characteristic changes in metabolic profiles of the colon cancer cells, revealing altered levels of amino acids, carnitine, and lipid markers. Most interestingly, with the assistance of targeted metabolite analysis, tryptophan (Trp) level was significantly increased whereas kynurenine (Kyn) level was decreased in colon cancer cells after celastrol treatment, together with markedly declined Kyn/Trp ratios. Western blot analysis revealed that expression of indoleamine 2,3-dioxygenase (IDO), the enzyme catalyzing Trp to generate Kyn, was dramatically inhibited in colon cancer cells after celastrol treatment, with a dose-dependent manner. These results suggest that suppression of IDO expression and tryptophan catabolism may be part of the mechanisms of celastrol in its cytotoxic effect against HCT116 colon cancer cells. This study provided scientific basis for further development of celastrol on treating colon cancer.

Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway

“…In the presence of ATP/dATP, Cytc, and apoptotic protease activator‐1 (Apaf‐1) form a polymer complex, which activates the precursor of Caspase‐9, leading to the activation of downstream effector Caspase‐3, and cutting the substrate to induce apoptosis . Numerous of evidence demonstrated that celastrol inhibit cancer cells proliferation through proapoptosis mechanism, including oral cancer, lung cancer, breast cancer, and colon cancer . In our study, western blotting and IF assays demonstrated that cleaved caspase‐3,9 were significantly increased when compared with the control groups, supporting that proapoptosis activity was induced after the celastrol treatment in CCA cells.…”

“…EMT is an important molecular mechanism of invasion and metastasis of malignant tumors . A large amount of evidence from experimental and clinical researches have highlight the important role of EMT in CCA metastasis .…”

Kunxian Capsule for Rheumatoid Arthritis: Inhibition of Inflammatory Network and Reducing Adverse Reactions Through Drug Matching

“…Another active ingredient of H.Lév. Hutch, Cel suppresses tryptophan catabolism, shows its cytotoxic effect against colon cancer cells (Qi et al, 2018).…”

Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor–tissue factor axis

“…Colon cancer cells such as HT-29, Caco-2, and LC-180 cells harbor the entire enzyme machinery for tryptophan catabolism, whose rate is several folds higher than that in normal colon epithelium. 38 Qi et al 39 showed that the human colon cancer cells grown in vitro converted tryptophan to Kyn and that the treatment with anticancer agents suppressed the generation of Kyn and resulted in the accumulation of tryptophan within the cancer cells and its milieu. However, such studies performed in a two-dimensional cell culture may not accurately reflect the metabolism of tumors in a three-dimensional structure.…”